Phase II study of Fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American brain tumor consortium study Article

Puduvalli, VK, Yung, WKA, Hess, KR et al. (2004). Phase II study of Fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American brain tumor consortium study . JOURNAL OF CLINICAL ONCOLOGY, 22(21), 4282-4289. 10.1200/JCO.2004.09.096

Open Access

cited authors

  • Puduvalli, VK; Yung, WKA; Hess, KR; Kuhn, JG; Groves, MD; Levin, VA; Zwiebel, J; Chang, SM; Cloughesy, TF; Junck, L; Wen, P; Lieberman, F; Conrad, CA; Gilbert, MR; Meyers, CA; Liu, V; Mehta, MP; Nicholas, MK; Prados, M

sustainable development goals

authors

publication date

  • November 1, 2004

webpage

published in

keywords

  • APOPTOSIS
  • BREAST-CANCER
  • CHEMOPREVENTION TRIAL
  • INDUCTION
  • Life Sciences & Biomedicine
  • N-(4-HYDROXYPHENYL) RETINAMIDE
  • Oncology
  • PHARMACOKINETICS
  • PLASMA
  • RETINOIC ACID
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • AMER SOC CLINICAL ONCOLOGY

start page

  • 4282

end page

  • 4289

volume

  • 22

issue

  • 21